Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Chemocentryx Inc (NQ: CCXI ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Oct 19, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Chemocentryx Inc < Previous 1 2 3 4 5 6 7 8 9 Next > NASDAQ:CCXI Long Term Shareholder Notice: Investigation over Potential Wrongdoing at ChemoCentryx, Inc. September 15, 2021 San Diego, CA -- (SBWIRE) -- 09/15/2021 -- Certain directors of ChemoCentryx, Inc. are under investigation concerning potential breaches of fiduciary duties. Via SBWire Topics Lawsuit Exposures Financial Legal ChemoCentryx's Return On Capital Employed Overview September 13, 2021 Benzinga Pro data, ChemoCentryx (NASDAQ:CCXI) reported Q2 sales of $1.81 million. Earnings fell to a loss of $38.74 million, resulting in a 32.09% decrease from last quarter. In... Via Benzinga ChemoCentryx, inc (CCXI) Q2 2021 Earnings Call Transcript August 10, 2021 CCXI earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial ChemoCentryx: Q2 Earnings Insights August 09, 2021 Shares of ChemoCentryx (NASDAQ:CCXI) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share fell 293.10% year over year to ($0.56... Via Benzinga Analyzing ChemoCentryx's Unusual Options Activity August 09, 2021 Shares of ChemoCentryx (NASDAQ:CCXI) saw some unusual opt... Via Benzinga The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight August 08, 2021 Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... Via Benzinga Exposures Product Safety Analyst Ratings For ChemoCentryx July 07, 2021 Analysts have provided the following ratings for ChemoCentryx (NASDAQ: Via Benzinga Why This ChemoCentryx Analyst Is Bullish July 06, 2021 H.C. Wainwright analysts remain bullish on ChemoCentryx, Inc. (NASDAQ: Via Benzinga Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates August 02, 2021 The month of July was disappointing from the perspective of Food and Drug Administration decisions, as the agency handed down mostly negative verdi... Via Benzinga 10 Health Care Stocks Showing Unusual Options Activity In Today's Session August 02, 2021 This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges... Via Benzinga Analyzing ChemoCentryx's Unusual Options Activity July 29, 2021 ChemoCentryx (NASDAQ:CCXI) shares experienced unusual options activity on Thursday. The stock price moved down to $15.19 following the option alert. Sentiment: BULLISH Option... Via Benzinga 2 Beaten-Down Biotech Stocks That Could Bounce Back July 27, 2021 The market hasn't been kind to these two drugmakers, but both have a chance to turn things around. Via The Motley Fool Exposures Product Safety The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix July 11, 2021 Biopharma stocks closed the holiday-shortened week lower amid a lack of any significant news flow. On the drug approval front, Provention Bio, Inc. (NASDAQ: PRVB) faced a setback... Via Benzinga Is Now the Time to Buy ChemoCentryx Stock? July 10, 2021 Analysts following this risky biotech stock have changed their tune. Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2021 July 07, 2021 Upgrades According to Raymond James, the prior rating for Sunnova Energy International Inc (N... Via Benzinga 10 Biggest Price Target Changes For Wednesday July 07, 2021 Keybanc cut Alibaba Group Holding Limited (NYSE: BABA) price target from $275 to $270. Alibaba shares rose 0.5% to $212.60 in pre-market trading. Needham boosted SMART Global... Via Benzinga ChemoCentryx Stock Is Approaching A Key Level July 06, 2021 ChemoCentryx Inc. (NASDAQ: CCXI) shares traded higher Tuesday after the company announced it filed an amendment to its New Drug Application for avacopan for the treatment of anti-... Via Benzinga ChemoCentryx Stock Jumps On Amendment In Avacopan Application, New Goal Date Of October 7 July 06, 2021 Following consultations with the FDA, ChemoCentryx Inc (NASDAQ: CCXI) filed an amendment to its marketing application seeking approval for avacopan to treat... Via Benzinga Exposures Product Safety Biotech Losers In 2021 That Could Bounce Big In The Second Half July 03, 2021 Biotech stocks are tricky investment bets that require careful analysis and scrutiny. Here's a list of biotech stocks that were among the worst performers in the first half but have the potential to... Via Talk Markets Biotech Losers In 2021 That Could Bounce Big In The Second Half July 03, 2021 Biotech stocks are tricky investment bets that require careful analysis and scrutiny. A stock that has fallen off a cliff in reaction to a binary event can neither be written off... Via Benzinga CCXI DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Investors of ChemoCentryx, Inc. of Deadline in Securities Fraud Class Action Lawsuit July 03, 2021 From Kessler Topaz Meltzer & Check, LLP Via Business Wire The Week Ahead In Biotech: Focus On Chemocentryx FDA Decision, Conference Presentations In A Light Week July 03, 2021 Biotech stocks advanced for a second week in running, with stocks reacting to pending releases for the second quarter and the first-half of the year. The week witnessed a few... Via Benzinga Exposures Product Safety CHEMOCENTRYX 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against ChemoCentryx, Inc. - CCXI July 02, 2021 From Kahn Swick & Foti, LLC Via Business Wire DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against ChemoCentryx, Inc. and Encourages Investors to Contact the Firm July 02, 2021 From Bragar Eagel & Squire, P.C. Via Business Wire Is It Too Late to Buy ChemoCentryx Stock? July 02, 2021 This biotech is traveling in uncharted waters. Via The Motley Fool Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates July 01, 2021 June was a month of plenty and also turned out to be a fruitful one from the perspective of Food and Drug Administration approvals. Regulatory reviews mostly produced positive... Via Benzinga CCXI CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against ChemoCentryx, Inc. June 30, 2021 NEW YORK, NY / ACCESSWIRE / June 30, 2021 / Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class... From Bernstein Liebhard LLP Via AccessWire Topics Lawsuit Exposures Financial Legal Product Safety The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ChemoCentryx, Inc. (CCXI) June 30, 2021 From The Law Offices of Frank R. Cruz Via Business Wire CCXI Approaching Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds ChemoCentryx, Inc. Investors of Class Action and Lead Plaintiff Deadline: July 6, 2021 June 30, 2021 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire TUESDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm June 30, 2021 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.